TrialEuropean journal of nuclear medicine and molecular imaging2014

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy.

E Seregni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.